Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5603507 | Heart Rhythm | 2017 | 26 Pages |
Abstract
In AF patients taking NOACs, being underweight was associated with an increased risk of major bleeding and all-cause death compared with being normal weight or overweight to obese, whereas the risk of thromboembolism was not different. Dose reduction should be considered in underweight patients who are at high risk for bleeding.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chan Soon MD, Eue-Keun MD, PhD, Hyue Mee MD, So-Ryoung MD, Myung-Jin MD, Seil MD, PhD, FHRS,